A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 455 participants.

Also called NCT05333835

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 455 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05333835
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05333835. Randomized; no masking; primary purpose treatment. Start 2022-07-08 (actual); primary completion 2024-03-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes
Intervention (Drug)
HR17031 injection
Intervention (Drug)
INS068 injection
Intervention (Drug)
SHR20004 injection
Lead sponsor
Jiangsu HengRui Medicine Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct05333835
Content hash
21f35c30fed118a7c170a0970954144216d32b56556de78ccb485fe747fac309